menu
    • menu

    Company profile for Sojournix

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sojournix is a clinical stage biopharmaceutical company focused on developing and commercializing novel therapies for the treatment of women’s health and neuroendocrine disorders. We are developing SJX-653, a novel and selective neurokinin-3 (NK3) antagonist as a once-daily non-hormonal therapy for moderate to severe vasomotor symptoms (VMS or hot flashes) due to menopause. An estimated 6,000 U.S. women reach menopause eve...
    Sojournix is a clinical stage biopharmaceutical company focused on developing and commercializing novel therapies for the treatment of women’s health and neuroendocrine disorders. We are developing SJX-653, a novel and selective neurokinin-3 (NK3) antagonist as a once-daily non-hormonal therapy for moderate to severe vasomotor symptoms (VMS or hot flashes) due to menopause. An estimated 6,000 U.S. women reach menopause every day (over two million per year) and the majority of these women experience vasomotor symptoms.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SojournixUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    400 Totten Pond Road Suite 110 Waltham, MA 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sojournixpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sojournix Advances Phase 2 Clinical Trial of SJX?653 for Menopausal Hot Flashes
    Sojournix Advances Phase 2 Clinical Trial of SJX?653 for Menopausal Hot Flashes

    08 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201208005235/en/Sojournix-Advances-Phase-2-Clinical-Trial-of-SJX%E2%80%91653-for-Menopausal-Hot-Flashes

    BUSINESSWIRE
    08 Dec 2020
    Share Share
    Sojournix Advances Phase 2 Clinical Trial of SJX?653 for Menopausal Hot Flashes
    Sojournix Advances Phase 2 Clinical Trial of SJX?653 for Menopausal Hot Flashes

    08 Dec 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201208005235/en

    BUSINESSWIRE
    08 Dec 2020
    Share Share
    Sojournix Announces Publication of Results from SJX-653 in JCEM
    Sojournix Announces Publication of Results from SJX-653 in JCEM

    21 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/sojournix-announces-publication-of-results-from-sjx-653-proof-of-mechanism-study-in-the-journal-of-clinical-endocrinology-and-amp-metabolism/

    BIOSPACE
    21 Sep 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search